Page last updated: 2024-08-24

aripiprazole and Depression

aripiprazole has been researched along with Depression in 58 studies

Research

Studies (58)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (10.34)	29.6817
2010's	37 (63.79)	24.3611
2020's	15 (25.86)	2.80

Authors

Authors	Studies
Bojarski, AJ; Bucki, A; Byrtus, H; Czopek, A; Kalinowska-Tłuścik, J; Kazek, G; Kołaczkowski, M; Partyka, A; Pawłowski, M; Piaskowska, A; Wesołowska, A	1
Bhat, V; Demchenko, I; Espinola, CW; Frey, BN; Ho, K; Kennedy, SH; Khoo, Y; Lam, RW; Lou, W; Milev, RV; Parikh, SV; Parmar, R; Ravindran, AV; Rotzinger, S	1
Carter, B; Cleare, AJ; Emre, C; Gnanapragasam, S; Hampsey, E; Korotkova, L; Martín-Dombrowski, J; Marwood, L; Scott, F; Strawbridge, R; Taylor, RW; Young, AH	1
Bleacher, H; DeSanto, K; Koerperich, L; Malam, N	1
Biała, G; Mikulska, J; Orzelska-Górka, J; Wiszniewska, A	1
Dashti, S; Nahavandi, A	1
Jha, MK; Mathew, SJ	1
Blumberger, DM; Brown, PJ; Cristancho, P; Flint, AJ; Gebara, MA; Gettinger, TR; Karp, JF; Lavretsky, H; Lenard, E; Lenze, EJ; Miller, JP; Mulsant, BH; Nicol, GE; Oughli, HA; Pham, VT; Reynolds, CF; Rollman, BL; Roose, SP; Yang, L	1
Lewis, G	1
Ebell, MH	1
Lu, Z; Wang, Y; Xun, G	1
Endo, K; Kodama, W; Terao, I; Tsuge, T	1
Cattaneo, D; Franco, G; Mauri, MC; Minutillo, A; Pace, CD; Paletta, S; Reggiori, A	1
Sichert, V; Volz, HP	1
Allen, TA; Frey, BN; Harkness, KL; Kennedy, SH; Lam, RW; Milev, R; Mueller, DJ; Quilty, LC; Uher, R	1
Bota, RG; Hazen, J; Howard, P; Nguyen, C; Novac, A; Tieu, R	1
Kus, K; Nowakowska, E; Ratajczak, P; Skurzyńska, M	1
Kobayashi, N; Takano, M	1
Beyer, JL; Johnson, KG	1
Johnson, GR; Mohamed, S; Park, A; Scrymgeour, A; Yoon, J; Zisook, S	1
Cardinale, M; Cungi, PJ; Meaudre, E	1
Hirakawa, M; Kunisawa, K; Libo, Z; Lu, Q; Mori, Y; Mouri, A; Nabeshima, T; Saito, K; Teshigawara, T; Yamamoto, Y; Yang, Y	1
Cichocki, M; Jarmuszkiewicz, Z; Kus, K; Nowakowska, E; Ratajczak, P; Woźniak, A	1
Crayton, J; Nasr, S; Popli, A; Wendt, B	1
Cichocki, M; Kus, K; Nowakowska, E; Ratajczak, P; Woźniak, A	1
Cornelius, V; Smith, L; Taylor, DM; Young, AH	1
Kobayashi, H; Tadori, Y	1
Meyer-Junco, LE	1
Aksoy-Poyraz, C; Duran, A; Öcek, T; Sakalli Kani, A; Turan, S	1
Ahn, SM; Choi, BT; Hong, KH; Kim, HN; Kim, YR; Pak, ME; Shin, HK	1
Abbate-Daga, G; Amianto, F; Desedime, N; Fassino, S; Giovannone, C; Marzola, E	1
De Santis, M; Deng, C; Huang, XF; Lian, J	1
Antoniów, M; Grześkowiak, E; Kus, K; Nowakowska, E; Ratajczak, P; Szkutnik-Fiedler, D	1
Baymeeva, NV; Burminskiy, DS; Miroshnichenko, II; Morozova, MA; Platova, AI; Potanin, SS	1
Aizenstein, HJ; Andreescu, C; Butters, MA; Karim, HT; Karp, JF; Reynolds, C; Smagula, SF; Tudorascu, D	1
Sewell, DD; Vahia, IV	1
Beslow, LA; Ghoshal, S; Guo, XM; Schilsky, ML; Schindler, EA; Schrag, M	1
Chen, SF; Shen, YC	1
Choi, BT; Hong, KW; Kim, HN; Kim, YR; Shin, HK	1
Bagchus, J	1
Gripeos, D; Sokolski, KN	1
Nakaya, M; Ohmori, K	1
Bria, P; Janiri, L; Mazza, M; Pecora, RD; Squillacioti, MR	2
Chandler, GM; Fava, M; Iosifescu, DV; Pollack, MH; Targum, SD	1
Hedlund, PB; Roberts, AJ; Sarkisyan, G	1
Friedman, JH	1
Aung, GL; Kawamoto, LS; O'Brien, JG; Tien, PG	1
Fountoulakis, KN; Schmidt, F; Vieta, E	1
Babu, GN; Chandra, P; Kumar, R; Saddichha, S	1
Burda, K; Czubak, A; Kus, K; Nowakowska, E; Ratajczak, P; Zin, J	1
Cavanna, AE; Rickards, H; Worrall, R	1
Bowden, CL; Carlson, BX; Eudicone, JM; Marcus, R; McQuade, RD; Nashat, M; Thase, ME	1
Citraro, R; Davoli, A; De Sarro, G; Di Paola, ED; Gallelli, L; Russo, E	1
Andersson, C; Findling, RL; Mankoski, R; Marcus, R; McQuade, R; Youngstrom, EA; Zhao, J	1
Capapey, J; Colom, F; Goikolea, JM; Grande, I; Sanchez-Moreno, J; Torres, I; Undurraga, J; Valentí, M; Vieta, E	1
Calabrese, JR; Carlson, BX; Carson, WH; Eudicone, JM; Keck, PE; Marcus, RN; McIntyre, RS; McQuade, RD; Sanchez, R	1

Reviews

12 review(s) available for aripiprazole and Depression

Article	Year
Systematic review and meta-analysis of augmentation and combination treatments for early-stage treatment-resistant depression. Journal of psychopharmacology (Oxford, England), 2023, Volume: 37, Issue:3 Topics: Adult; Aripiprazole; Depression; Depressive Disorder, Major; Humans; Ketamine; Risperidone	2023
Are antipsychotics effective adjunctive Tx for patients with moderate-to-severe depression? The Journal of family practice, 2022, Volume: 71, Issue:6 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Depression; Humans; Olanzapine; Quetiapine Fumarate	2022
New Atypical Antipsychotics in the Treatment of Schizophrenia and Depression. International journal of molecular sciences, 2022, Sep-13, Volume: 23, Issue:18 Topics: Antipsychotic Agents; Aripiprazole; Depression; Humans; Lurasidone Hydrochloride; Psychotropic Drugs; Schizophrenia	2022
Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape. The American journal of psychiatry, 2023, 03-01, Volume: 180, Issue:3 Topics: Adult; Antipsychotic Agents; Aripiprazole; Depression; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Drug-Related Side Effects and Adverse Reactions; Humans; United States	2023
Comparative efficacy, tolerability and acceptability of intravenous racemic ketamine with intranasal esketamine, aripiprazole and lithium as augmentative treatments for treatment-resistant unipolar depression: A systematic review and network meta-analysis Journal of affective disorders, 2024, Feb-01, Volume: 346 Topics: Adult; Antidepressive Agents; Aripiprazole; Depression; Depressive Disorder; Depressive Disorder, Treatment-Resistant; Humans; Ketamine; Lithium; Network Meta-Analysis	2024
Advances in Pharmacotherapy of Late-Life Depression. Current psychiatry reports, 2018, 04-07, Volume: 20, Issue:5 Topics: Antidepressive Agents; Aripiprazole; Depression; Depressive Disorder; Drug Resistance; Duloxetine Hydrochloride; Humans; Paroxetine; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Vortioxetine	2018
Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis. Acta psychiatrica Scandinavica, 2014, Volume: 130, Issue:6 Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Depression; Dibenzothiazepines; Drug Therapy, Combination; Fluoxetine; Humans; Isoindoles; Lamotrigine; Lithium Compounds; Lurasidone Hydrochloride; Monoamine Oxidase Inhibitors; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Thiazoles; Treatment Outcome; Triazines; Valproic Acid	2014
[In vitro pharmacology of antipsychotics at human dopamine D2 and D3 receptors]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2014, Volume: 144, Issue:6 Topics: Animals; Antipsychotic Agents; Aripiprazole; CHO Cells; Cricetulus; Depression; Dopamine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Piperazines; Quinolones; Receptors, Dopamine D2; Receptors, Dopamine D3; Schizophrenia; Synaptic Transmission	2014
Aripiprazole monotherapy in the treatment of bipolar disorder: a meta-analysis. Journal of affective disorders, 2011, Volume: 133, Issue:3 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depression; Humans; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Treatment Outcome	2011
Aripiprazole in bipolar depression: a pooled, post-hoc analysis by severity of core depressive symptoms. International journal of psychiatry in clinical practice, 2012, Volume: 16, Issue:2 Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Body Weight; Depression; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Nausea; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Treatment Outcome; Young Adult	2012
Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity. Neuropharmacology, 2013, Volume: 64 Topics: Animals; Anticonvulsants; Antidepressive Agents; Aripiprazole; Behavior, Animal; Cognition; Cognition Disorders; Depression; Disease Models, Animal; Epilepsy, Absence; Nootropic Agents; Piperazines; Quinolones; Rats; Rats, Inbred Strains	2013
Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol. Journal of affective disorders, 2013, Jan-25, Volume: 144, Issue:3 Topics: Acute Disease; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Depression; Depressive Disorder; Dibenzothiazepines; Double-Blind Method; Drug Industry; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Research Support as Topic; Risperidone; Thiazoles	2013

Trials

8 trial(s) available for aripiprazole and Depression

Article	Year
Antidepressant Augmentation versus Switch in Treatment-Resistant Geriatric Depression. The New England journal of medicine, 2023, Mar-23, Volume: 388, Issue:12 Topics: Aged; Antidepressive Agents; Aripiprazole; Bupropion; Depression; Drug Therapy, Combination; Humans; Lithium Compounds; Nortriptyline; Treatment Switching	2023
Effect of aripiprazole on promoting cognitive function and enhancing clinical efficacy in patients with first-episode depression on escitalopram: A randomized controlled trial. Journal of affective disorders, 2024, 01-01, Volume: 344 Topics: Antidepressive Agents; Aripiprazole; Citalopram; Cognition; Depression; Depressive Disorder, Major; Double-Blind Method; Escitalopram; Humans; Treatment Outcome	2024
Comparing Cost-Effectiveness of Aripiprazole Augmentation With Other "Next-Step" Depression Treatment Strategies: A Randomized Clinical Trial. The Journal of clinical psychiatry, 2018, 12-18, Volume: 80, Issue:1 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Aripiprazole; Bupropion; Cost-Benefit Analysis; Depression; Depressive Disorder, Major; Drug Substitution; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Remission Induction; United States; United States Department of Veterans Affairs; Veterans	2018
Effect of aripiprazole on self-reported anhedonia in bipolar depressed patients. Psychiatry research, 2009, Jan-30, Volume: 165, Issue:1-2 Topics: Adult; Affect; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Personality Inventory; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Psychometrics; Quinolones	2009
Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial. Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:18 Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Body Weight; Depression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Headache; Humans; Lorazepam; Male; Middle Aged; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Young Adult	2008
RESEARCH: Validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ). CNS neuroscience & therapeutics, 2010, Volume: 16, Issue:5 Topics: Antipsychotic Agents; Aripiprazole; Depression; Double-Blind Method; Female; Humans; Male; Massachusetts; Piperazines; Quinolones; Reproducibility of Results; Self Report; Surveys and Questionnaires	2010
Respondent and item level patterns of response of aripiprazole in the acute treatment of pediatric bipolar I disorder. Journal of affective disorders, 2012, Dec-20, Volume: 143, Issue:1-3 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Depression; Double-Blind Method; Female; Humans; Male; Parents; Piperazines; Psychiatric Status Rating Scales; Quinolones; Treatment Outcome	2012
Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:10 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depression; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Administration Schedule; Female; GABA Modulators; Humans; Lorazepam; Male; Piperazines; Prevalence; Prospective Studies; Quinolones; Remission Induction; Secondary Prevention; Severity of Illness Index; Surveys and Questionnaires	2007

Other Studies

38 other study(ies) available for aripiprazole and Depression

Article	Year
Novel spirohydantoin derivative as a potent multireceptor-active antipsychotic and antidepressant agent. Bioorganic & medicinal chemistry, 2015, Jul-01, Volume: 23, Issue:13 Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Depression; Dextroamphetamine; Hydantoins; Hyperkinesis; Imidazolidines; Male; Mice; Piperazines; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Serotonin; Structure-Activity Relationship; Swimming	2015
Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapy. Brain and behavior, 2022, Volume: 12, Issue:5 Topics: Aripiprazole; Depression; Depressive Disorder, Major; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Escitalopram; Humans; Treatment Outcome	2022
Neuroprotective effects of aripiprazole in stress-induced depressive-like behavior: Possible role of CACNA1C. Journal of chemical neuroanatomy, 2022, Volume: 126 Topics: Animals; Antidepressive Agents; Aripiprazole; Behavior, Animal; Brain-Derived Neurotrophic Factor; Calcium Channels, L-Type; Depression; Disease Models, Animal; GAP-43 Protein; Hippocampus; Interleukin-6; Neuroprotective Agents; Rats; Stress, Psychological	2022
Aripiprazole Augmentation in Older Persons with Treatment-Resistant Depression. The New England journal of medicine, 2023, Mar-23, Volume: 388, Issue:12 Topics: Aged; Aged, 80 and over; Antidepressive Agents; Aripiprazole; Depression; Depressive Disorder, Treatment-Resistant; Drug Therapy, Combination; Humans; Treatment Outcome	2023
Cariprazine (Vraylar) for adjunctive treatment of depression. The Medical letter on drugs and therapeutics, 2023, 05-29, Volume: 65, Issue:1677 Topics: Antipsychotic Agents; Aripiprazole; Depression; Humans; Piperazines	2023
Augmentation With Aripiprazole or Bupropion, or a Switch to Nortriptyline, Effective for Treatment-Resistant Depression in Older Adults. American family physician, 2023, Volume: 108, Issue:3 Topics: Aged; Aripiprazole; Bupropion; Depression; Depressive Disorder, Treatment-Resistant; Humans; Nortriptyline	2023
Paliperidone LAI and Aripiprazole LAI Plasma Level Monitoring in the Prophylaxis of Bipolar Disorder Type I with Manic Predominance. Pharmacopsychiatry, 2020, Volume: 53, Issue:5 Topics: Adolescent; Adult; Aged; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Delayed-Action Preparations; Depression; Female; Humans; Injections; Male; Mania; Middle Aged; Paliperidone Palmitate; Prospective Studies; Psychiatric Status Rating Scales; Treatment Outcome; Young Adult	2020
Rapid efficacy of aripiprazole in the treatment of catatonic depression/catatonia with consideration of the drug's unique receptor profile: a case report. Fortschritte der Neurologie-Psychiatrie, 2021, Volume: 89, Issue:4 Topics: Antipsychotic Agents; Aripiprazole; Catatonia; Depression; Humans; Pharmaceutical Preparations	2021
Interactions between neuroticism and stressful life events predict response to pharmacotherapy for major depression: A CAN-BIND 1 report. Personality and mental health, 2021, Volume: 15, Issue:4 Topics: Aripiprazole; Depression; Depressive Disorder, Major; Escitalopram; Humans; Neuroticism	2021
Weight gain changes in patients with aripiprazole monotherapy compared with aripiprazole-antidepressant polypharmacy in an outpatient sample. Journal of psychopharmacology (Oxford, England), 2018, Volume: 32, Issue:4 Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Body Mass Index; Cohort Studies; Depression; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mood Disorders; Outpatients; Polypharmacy; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Weight Gain	2018
The influence of aripiprazole and venlafaxine on the antidepressant-like effect observed in prenatally stressed rats (animal model of depression). Human & experimental toxicology, 2018, Volume: 37, Issue:9 Topics: Animals; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Depression; Disease Models, Animal; Drug Therapy, Combination; Female; Locomotion; Male; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Wistar; Stress, Psychological; Swimming; Venlafaxine Hydrochloride	2018
Aripiprazole-induced sleep-related eating disorder: a case report. Journal of medical case reports, 2018, Apr-05, Volume: 12, Issue:1 Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Depression; Drug Therapy, Combination; Humans; Male; Night Eating Syndrome; Sertraline; Sleep Wake Disorders	2018
Green plasma and a blocked CRRT circuit due to drug-induced hyperlipidemia. Intensive care medicine, 2019, Volume: 45, Issue:9 Topics: Antidepressive Agents; Aripiprazole; Blood; Depression; Female; Humans; Hyperlipidemias; Middle Aged; Respiratory Insufficiency	2019
Chronic unpredictable mild stress-induced behavioral changes are coupled with dopaminergic hyperfunction and serotonergic hypofunction in mouse models of depression. Behavioural brain research, 2019, 10-17, Volume: 372 Topics: Animals; Aripiprazole; Behavior, Animal; Depression; Depressive Disorder, Major; Disease Models, Animal; Dopamine; Fluoxetine; Hippocampus; Male; Mice; Mice, Inbred C57BL; Nucleus Accumbens; Prefrontal Cortex; Serotonin; Signal Transduction; Stress, Psychological; Tryptophan Hydroxylase; Tyrosine 3-Monooxygenase	2019
Influence of aripiprazole and olanzapine on behavioral dysfunctions of adolescent rats exposed to stress in perinatal period. Pharmacological reports : PR, 2013, Volume: 65, Issue:1 Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Benzodiazepines; Cognition Disorders; Depression; Disease Models, Animal; Drug Administration Schedule; Female; Male; Maze Learning; Memory Disorders; Olanzapine; Piperazines; Pregnancy; Prenatal Exposure Delayed Effects; Quinolones; Rats; Rats, Wistar; Schizophrenia; Stress, Psychological; Time Factors	2013
Comparing outcomes of adjunctive treatment in depression: aripiprazole versus bupropion. Journal of affective disorders, 2014, Volume: 162 Topics: Adult; Antidepressive Agents; Aripiprazole; Bupropion; Depression; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piperazines; Quinolones; Retrospective Studies	2014
The influence of aripiprazole, olanzapine and enriched environment on depressant-like behavior, spatial memory dysfunction and hippocampal level of BDNF in prenatally stressed rats. Pharmacological reports : PR, 2014, Volume: 66, Issue:3 Topics: Animals; Antidepressive Agents; Aripiprazole; Benzodiazepines; Brain-Derived Neurotrophic Factor; Depression; Environment; Female; Hippocampus; Male; Maze Learning; Memory Disorders; Olanzapine; Piperazines; Pregnancy; Quinolones; Rats; Rats, Wistar; Spatial Memory	2014
Aripiprazole for the treatment of depression in palliative care. Journal of palliative medicine, 2015, Volume: 18, Issue:4 Topics: Antipsychotic Agents; Aripiprazole; Depression; Humans; Palliative Care; Terminally Ill	2015
Aripiprazole-induced acute hiccups: a case report. The Journal of neuropsychiatry and clinical neurosciences, 2015,Winter, Volume: 27, Issue:1 Topics: Antipsychotic Agents; Aripiprazole; Depression; Hiccup; Humans; Male; Middle Aged; Piperazines; Quinolones	2015
Studies on the animal model of post-stroke depression and application of antipsychotic aripiprazole. Behavioural brain research, 2015, Volume: 287 Topics: Animals; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Brain; Depression; Disease Models, Animal; Dopaminergic Neurons; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred C57BL; Stress, Psychological; Stroke	2015
Atypical antipsychotics as augmentation therapy in anorexia nervosa. PloS one, 2015, Volume: 10, Issue:4 Topics: Adult; Anorexia Nervosa; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Depression; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Olanzapine; Selective Serotonin Reuptake Inhibitors; Serotonin	2015
Early antipsychotic treatment in childhood/adolescent period has long-term effects on depressive-like, anxiety-like and locomotor behaviours in adult rats. Journal of psychopharmacology (Oxford, England), 2016, Volume: 30, Issue:2 Topics: Age Factors; Animals; Antipsychotic Agents; Anxiety; Aripiprazole; Behavior, Animal; Benzodiazepines; Depression; Female; Male; Motor Activity; Olanzapine; Rats; Rats, Sprague-Dawley; Risperidone; Sex Factors; Time Factors	2016
Coadministration of tramadol with aripiprazole and venlafaxine--The effect on spatial memory functions in male rats. Pharmacological reports : PR, 2016, Volume: 68, Issue:2 Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Chronic Pain; Depression; Disease Models, Animal; Male; Maze Learning; Memory Disorders; Rats; Rats, Wistar; Spatial Memory; Tramadol; Venlafaxine Hydrochloride	2016
[Plasma levels of antipsychotics and the severity of side-effects in the treatment of schizophrenia exacerbation]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2015, Volume: 115, Issue:11 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Glucose; Clozapine; Depression; Drug Therapy, Combination; Female; Haloperidol; Humans; Hyperprolactinemia; Male; Middle Aged; Olanzapine; Prolactin; Risperidone; Schizophrenia; Schizophrenic Psychology; Young Adult	2015
Intrinsic functional connectivity in late-life depression: trajectories over the course of pharmacotherapy in remitters and non-remitters. Molecular psychiatry, 2017, Volume: 22, Issue:3 Topics: Aged; Aripiprazole; Brain; Brain Mapping; Depression; Depressive Disorder; Executive Function; Female; Frontal Lobe; Humans; Image Processing, Computer-Assisted; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Neural Pathways; Neuropsychological Tests; Parietal Lobe; Rest; Temporal Lobe; Venlafaxine Hydrochloride	2017
Late-Life Depression: A Role for Accelerometer Technology in Diagnosis and Management. The American journal of psychiatry, 2016, Aug-01, Volume: 173, Issue:8 Topics: Actigraphy; Aged, 80 and over; Antidepressive Agents; Aripiprazole; Depression; Exercise; Fluoxetine; Humans; Male; Sleep Wake Disorders	2016
Neuropsychiatric Presentation of Wilson Disease in an Adolescent Male. Neuropediatrics, 2016, Volume: 47, Issue:5 Topics: Adenosine Triphosphatases; Adolescent; Aggression; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Brain; Cation Transport Proteins; Citalopram; Copper-Transporting ATPases; Depression; Diplopia; Dysarthria; Esophageal and Gastric Varices; Hepatolenticular Degeneration; Humans; Hypertension, Portal; Impulsive Behavior; Liver Cirrhosis; Magnetic Resonance Imaging; Male; Mutation; Suicidal Ideation	2016
5-HT1A C-1019G (rs6295) Predicts Aripiprazole Treatment Response Specifically for Cognitive and Depressive Symptoms in Schizophrenia. Journal of clinical psychopharmacology, 2017, Volume: 37, Issue:1 Topics: Adult; Antipsychotic Agents; Aripiprazole; Cognitive Dysfunction; Depression; Female; Humans; Male; Receptor, Serotonin, 5-HT1A; Schizophrenia; Serotonin 5-HT1 Receptor Agonists; Young Adult	2017
Antidepressant Effects of Aripiprazole Augmentation for Cilostazol-Treated Mice Exposed to Chronic Mild Stress after Ischemic Stroke. International journal of molecular sciences, 2017, Feb-08, Volume: 18, Issue:2 Topics: Animals; Antidepressive Agents; Aripiprazole; Atrophy; Behavior, Animal; Brain; Cell Differentiation; Cell Proliferation; Cilostazol; CREB-Binding Protein; Depression; Disease Models, Animal; Drug Synergism; Male; Mice; Neural Stem Cells; Phenotype; Phosphorylation; Stress, Psychological; Stroke; Tetrazoles	2017
[Reaction to 'Augmentation with atypical antipsychotics in the treatment of patients with a therapy-resistant depression: a review']. Tijdschrift voor psychiatrie, 2008, Volume: 50, Issue:6 Topics: Antipsychotic Agents; Aripiprazole; Depression; Evidence-Based Medicine; Humans; Piperazines; Quinolones; Treatment Outcome	2008
Remission of chronic severe selective serotonin-reuptake inhibitor/selective norepinephrine-reuptake inhibitor refractory depression following adjunctive aripiprazole. The Annals of pharmacotherapy, 2008, Volume: 42, Issue:9 Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Chronic Disease; Depression; Drug Therapy, Combination; Female; Humans; Middle Aged; Norepinephrine; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors	2008
Aripiprazole treatment for depression in schizoaffective disorder. Progress in neuro-psychopharmacology & biological psychiatry, 2008, Dec-12, Volume: 32, Issue:8 Topics: Adult; Antipsychotic Agents; Aripiprazole; Depression; Female; Humans; Piperazines; Psychotic Disorders; Quinolones	2008
The 5-HT(7) receptor as a mediator and modulator of antidepressant-like behavior. Behavioural brain research, 2010, May-01, Volume: 209, Issue:1 Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Citalopram; Corticosterone; Depression; Disease Models, Animal; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Hindlimb Suspension; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Phenols; Piperazines; Quinolones; Receptors, Serotonin; Serotonin Antagonists; Sulfonamides; Swimming	2010
Warning on treating depression. Medicine and health, Rhode Island, 2010, Volume: 93, Issue:3 Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Depression; Dopamine Antagonists; Gastrointestinal Diseases; Humans; Metoclopramide; Piperazines; Quinolones	2010
Increased aripiprazole concentrations in an HIV-positive male concurrently taking duloxetine, darunavir, and ritonavir. The Annals of pharmacotherapy, 2010, Volume: 44, Issue:11 Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Cytochrome P-450 Enzyme Inhibitors; Darunavir; Depression; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; HIV Infections; HIV Protease Inhibitors; Humans; Male; Piperazines; Quinolones; Ritonavir; Sulfonamides; Thiophenes	2010
Aripiprazole associated with acute dystonia, akathisia, and parkinsonism in a single patient. Journal of clinical pharmacology, 2012, Volume: 52, Issue:9 Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Aripiprazole; Depression; Dystonia; Female; Fluoxetine; Humans; Parkinsonian Disorders; Piperazines; Psychotic Disorders; Quinolones	2012
Influence of aripiprazole on the antidepressant, anxiolytic and cognitive functions of rats. Pharmacological reports : PR, 2011, Volume: 63, Issue:4 Topics: Animals; Antipsychotic Agents; Anxiety; Aripiprazole; Behavior, Animal; Cognition; Depression; Disease Models, Animal; Male; Maze Learning; Memory; Piperazines; Quinolones; Rats; Rats, Wistar; Toxicity Tests	2011
Treatment practices in Tourette syndrome: the European perspective. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2012, Volume: 16, Issue:4 Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Depression; Europe; Fluoxetine; Fluvoxamine; Health Care Surveys; Humans; Methylphenidate; Obsessive-Compulsive Disorder; Physicians; Piperazines; Propylamines; Psychiatry; Quinolones; Risperidone; Sertraline; Sulpiride; Tourette Syndrome	2012